𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Engaging leaders as builders of sustainable rural communities: A case study

✍ Scribed by Molly M. Clark; Ed Davis

Publisher
John Wiley and Sons
Year
2007
Weight
91 KB
Volume
2007
Category
Article
ISSN
0194-3081

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Community development using a sustainabl
Community development using a sustainable tourism strategy: a case study of the Jordan River Valley touristway
✍ Mohammed Shunnaq; William A. Schwab; Margaret F. Reid 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 1 views

## Abstract This paper presents the results of a 10‐year collaboration among Yarmouk University, the University of Arkansas and the Jordanian government to develop a sustainable tourism strategy against the backdrop of political and economic uncertainty. It reports our efforts to develop a touristw

Familial influence on parkinsonism in a
Familial influence on parkinsonism in a rural area of Turkey (Kızılcaboluk–Denizli): A community-based case-control study
✍ Fusun Duzcan; Mehmet Zencir; Fatma Ozdemir; G. Ozan Cetin; Huseyin Bagci; Peter 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract This population‐based study on parkinsonism in a genetically isolated community from a rural area of Turkey aimed to provide a selective evaluation of environmental and heritable risk factors. An increased prevalence of parkinsonism (4.1%) was detected in the village of Kızılcaboluk for

A matched case-controlled study of 48 an
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response
✍ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Substitution of amino acid (aa) 70 and 91 in the core region of HCV genotype 1b is a useful pretreatment predictor of efficacy of 48‐week peginterferon (PEG‐IFN) plus ribavirin (RBV) therapy. Here, we determined the efficacy of 72‐week PEG‐IFN/RBV and the predictive factors to such ther